Replies to post #183457 on NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Do you think this could be a hint that by that time no topline results will be out?

What I think, Virgilio, if I can speak bluntly, is that you are trying to place that hint or thought into our heads. Frankly, this is an Immuno-Oncology Summit where Dr. Bosch will likely educate experts in this field about a vaccine, DCVaxL, that may well be the next standard of care in GBM, if not in most cancers. I am pretty sure that nobody sat around the NWBO office saying, “how can we hint of no topline results soon? Oh, let’s send Marnix to this summit in late August!!”
Of course not! That’s absolutely silly to suggest.
If it is a hint at anything, it’s a hint that NWBO wants to educate doctors - and I assume doctors will be represented st this summit - about the next standard of care.
I don’t know if this is Dr. Bosch’s first time in attendance here, or if this is an ongoing appearance by him. If it’s a new venue for him, it may speak volumes on where NWBO sees DCVax as being in this community by August 29th.
The title of his talk, the Clinical Development of Dendritic Cell-based Immunotherapies for Cancer, doesn’t indicate if he’ll talk about the Phase III trial in the past tense, as if it’s over, or in the present tense, as if it’s continuing. But what the title actually says, no hinting around at all, is that he’ll talk about multiple clinical immunotherapies. So, I think your question to me should have read, “do you think this could be a hint that the other trials involving DCVaxL and DCVax Direct will be enrolling on or about this date, August 29?”
My answer to that question is yes, I think the use of the word “immunotherapies” is a clue that we may be seeing the start up of multiple trials around the time of this summit.